Ranjan Upadhyay

3 weeks ago | nature.com | Hind Rafei |Rafet Basar |Sunil P Acharya |Vakul Mohanty |Ranjan Upadhyay |Merve Dede | +12 more

AbstractChimeric antigen receptor (CAR) natural killer (NK) cell immunotherapy offers a promising approach against cancer1,2,3. However, the molecular mechanisms that regulate CAR-NK cell activity remain unclear. Here we identify the transcription factor cyclic AMP response element modulator (CREM) as a crucial regulator of NK cell function.